A randomized multi-center trial of elective revascularization with EPC [endothelial progenitor cell] capturing stenting versus drug eluting stenting in patients with de novo coronary lesions with a high risk of coronary restenosis: The Genous EPC capturing stent versus the paclitaxel or sirolimus eluting stent.
Latest Information Update: 28 Mar 2014
At a glance
- Drugs Anti-CD34 monoclonal antibody (Primary) ; Everolimus; Paclitaxel; Sirolimus; Zotarolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms TRIAS-HR
- 25 Jun 2007 New trial record.